Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Alex Blostein

Goldman Sachs · covers Financial Services

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).

Questions
141on tracked calls
Challenge rate
9%12 of 141 questions
Companies
18questioned at least once
Reporting periods
8with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 141 of 141 questions from 18 companies

RJFRaymond James Financial16 questions · 8 reporting periods · 2 of 16 challenging
RJF company page →

Calendar 2026 Q2

just a cleanup on the legal reserve, how much was that this quarter?

Regulation PolicyCost PressureTranscript · FY2026 Q3 →
Show response

Paul declined to disclose the specific figure but confirmed it drove most of the professional-fee increase; partially answered.

talk about the ability to drive positive operating loans from here if the banking backdrop does not really improve

MarginRevenue GrowthTranscript · FY2026 Q3 →
Show response

Butch confirmed the firm is at its ~20% adjusted pretax margin target while investing in growth, citing rates and M&A as catalysts.

Calendar 2026 Q1

Where are the odds of that today? So you sort of think about your pipeline of corporate M&A, particularly in the wealth space

M&ACapital AllocationTranscript · FY2026 Q2 →
Show response

Shoukry noted great competitors with strong cultures simply haven't been for sale. RJF invites firms to join the family rather than doing takeovers. Cited Morgan Keegan (2012) where legacy leadership still in place and Memphis headcount has grown. Patient approach, maintaining relationships with friendly competitors. Confident families will join at some point.

what do you think the margins could go to over time

Show response

Shoukry acknowledged significant Agentic AI opportunities ahead but called it too early to dimension margin impact. Currently piloting Ray with hundreds of advisers with extremely positive early feedback. Using AI in cybersecurity and other areas. Compute power investment substantial. Corporate America broadly still early in Agentic AI journey.

Calendar 2025 Q4

Can you maybe elaborate on what specifically is going into that growth this year

Capex InvestmentCloud & AITranscript · FY2026 Q1 →
Show response

Shoukry cited cybersecurity, AI application development, and infrastructure investment. Noted smaller firms struggle to remain competitive without $1B+ annual technology spend. Recruited advisers discovering technology gap after moving. Long-term AI efficiency gains expected but too early to dimension or put timeline on.

It seems the past couple of quarters has been closer to like $350 to $400 million range, including the target for the fiscal second. Can you kind of walk through the rationale

Capital AllocationTranscript · FY2026 Q1 →
Show response

Shoukry framed Q1 as $400M buyback plus $80M preferred redemption = $480M total capital deployment. Reiterated $400-500M quarterly buyback target going forward while monitoring Tier 1 leverage ratio. Will adjust if other capital priorities arise.

Calendar 2025 Q3

Maybe can you expand on some of the financial parameters, the criteria that you guys would look for, for a larger-sized deal

M&ACapital AllocationTranscript · FY2025 Q4 →
Show response

Shoukry reiterated three criteria: cultural fit (most important), strategic fit (1+1 > 2 with leadership retention track record), and valuation. Cited Morgan Keegan (2012), consumer IB, and TriState as examples of retained leadership. Have lots of capital/liquidity and actively looking across all businesses.

was this related to GreensLedge acquisition in the quarter? Or should we take it as a signal that maybe there's something bigger that's imminent

Capital AllocationTranscript · FY2025 Q4 →
Show response

Oorlog explained buyback pause was from senior note offering, not M&A signaling. Combined $350M buybacks + $98M sub-note redemption = $450M total capital deployment, within $400-500M quarterly target. Shoukry confirmed target unchanged going forward.

Calendar 2025 Q2

Is the pipeline in banking what are you seeing right now and stuff that's sort of tangible enough to get you guys into that 20-plus percent pretax margin goal

ChallengingMarginRevenue GrowthTranscript · FY2025 Q3 →
Show response

Oorlog noted 19% adjusted pretax margin was solid given capital markets softness. Improvement in capital markets plus 8% increase in fee billable assets for Q4 provide tailwinds to reach 20% target from Investor Day.

How are you thinking about that for AJ? It feels like the opportunity to increased penetration of alternative products

Product LaunchDemandTranscript · FY2025 Q3 →
Show response

Shoukry emphasized headroom in private markets penetration. New leadership team in place for 4 months investing in education and awareness. Will not push products or create quotas/variable incentives. Demand-driven approach consistent with culture.

Calendar 2025 Q1

Maybe spend a minute on kind of what does that look like today at RayJay

Product LaunchDemandTranscript · FY2025 Q2 →
Show response

Shoukry described wide product range from alternative mutual funds to private investments for $50M+ clients. Open architecture platform with new private placements head bridging Capital Markets and PCG. Penetration still relatively low.

what's been, I guess, the problem in the last year or so? What do you think could change to get you guys back to this 5% plus

ChallengingSubscriber GrowthTranscript · FY2025 Q2 →
Show response

Shoukry pushed back on characterization, noting last quarter was 4% (mid-5s ex-OSJ departure). Emphasized March and April new commits accelerating. Confident in best-in-class NNA growth trajectory.

Calendar 2024 Q4

how much the underlying drivers of the business have expanded over the last couple of years

Revenue GrowthDemandTranscript · FY2025 Q1 →
Show response

Reilly cautioned against extrapolating last two quarters as run rate. Q4 and Q1 benefited from early recovery and large individual fees. Pipeline strong but M&A is inherently lumpy.

can you give us a sense of realistically when you expect to get there not to pin you down to any particular quarter

Capital AllocationTranscript · FY2025 Q1 →
Show response

Shoukry asked for patience noting they were at 10% just two years ago and did six acquisitions in that period. Reilly noted they decelerated buybacks prudently due to active acquisition due diligence.

Calendar 2024 Q3

Should we assume that to be kind of run rate quarterly pace of buybacks from here as well or absent, obviously, like M&A

Capital AllocationTranscript · FY2024 Q4 →
Show response

Shoukry reiterated preference for organic growth and acquisitions over buybacks. Will maintain or increase buyback pace to limit further capital ratio expansion above 10% target.

Is it possible to unpack sort of sources of growth you saw in the third quarter, your fiscal fourth quarter across the cash stack

Subscriber GrowthDemandTranscript · FY2024 Q4 →
Show response

Shoukry attributed cash growth to new advisor onboarding, previously masked by reinvestment activity. Decelerating reinvestment revealing underlying organic cash growth.

BNYBNY Mellon13 questions · 7 reporting periods · 0 of 13 challenging
BNY company page →

Calendar 2026 Q2

how do you think deposit betas will perform both in the U.S. and outside the U.S.

MacroeconomicMarginTranscript · FY2026 Q2 →
Show response

Dermot guided deposit betas roughly in line with the last cycle, about 80% for dollars and 60-70% for euros and sterling, noting BNY is predominantly a dollar book.

what the destination for profitability could be, in the business as a whole over the next couple years

MarginGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Dermot framed the medium term targets as through cycle miles rather than endpoints and declined to put a specific number on the profitability ceiling.

Calendar 2026 Q1

how does that inform your 10% NII guide

Revenue GrowthDemandTranscript · FY2026 Q1 →
Show response

CFO expects balances to moderate seasonally from Q1 with Q3 weakest and Q4 strongest. Over the full year, balances expected modestly higher than 2025. Multiple rate and balance scenarios run to support the 10% NII guide.

how much of the benefit the elevated market volatility contributed this quarter to think about the right baseline

Revenue GrowthMacroeconomicTranscript · FY2026 Q1 →
Show response

CFO described balanced revenue between volume-driven and balance-driven fees, with balanced equity/fixed income mix. Noted 3% investment-related gains contribution to Securities Services 39% PTM. Record sales quarter shows clients doing more across platforms.

Calendar 2025 Q4

as you think about organic fee growth into '26 and beyond, any way to frame what that could look like

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

CFO cited three consecutive years of core fee sales growth, 64% increase in multi-product clients, and 10% of sales from new logos. New Chief Product and Innovation Officer expected to drive similar impact as commercial model. CEO added multiple megatrends as tailwinds.

I don't think I heard you guys talk about the capital return plans for 2026 specifically

Capital AllocationMarginTranscript · FY2025 Q4 →
Show response

CFO said capital philosophy unchanged with Tier 1 leverage ratio target at upper end of 5.5-6% range. Total payout ratio expected in 95-105% range, consistent with prior years. No longer feels necessary to separately guide on buybacks given overall algorithm.

Calendar 2025 Q3

as you think about firm-wide margin in this kind of mid-30s year to date and as you think about the forward opportunity set

MarginInnovation & R&DTranscript · FY2025 Q3 →
Show response

CFO cited consistent delivery above best-in-class 150bps operating leverage benchmark over three years. Still early in decade-long transformation with platform benefits, product innovation under new CPO, and AI opportunities not yet factored in.

if you think about Q4 guide, is that a reasonable jumping-off point for NII for all of 2026

Revenue GrowthCapital AllocationTranscript · FY2025 Q3 →
Show response

CFO confirmed proactive 2026 balance sheet repositioning has been done, replicating the Jackson Hole pivot approach, and stated Q4 is a good base case jumping-off point for 2026 NII.

Calendar 2025 Q2

where do you see both risk to, you know, the existing business and some of the new revenue opportunities

Innovation & R&DCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

CEO saw net positive from digital disruption, noting BNY provides traditional banking rails, on/off-ramp services, native Bitcoin custody, and stablecoin reserve custody spanning multiple platform synergies.

Calendar 2025 Q1

Can you comment also on the mix between interest-bearing and noninterest-bearing in April

Revenue GrowthMacroeconomicTranscript · FY2025 Q1 →
Show response

CFO attributed NII confidence to proactive balance sheet actions taken after Jackson Hole last summer, noting even 50bp Fed cut would not materially impact the full-year NII outlook.

How are you thinking about that? Maybe it's too early, but just want to get your sense for appetite for M&A

M&ACapital AllocationTranscript · FY2025 Q1 →
Show response

CEO emphasized disciplined approach to M&A with clear criteria: strategic alignment, cultural fit, and attractive returns. Cited Archer acquisition as practice for future integration capabilities.

Calendar 2024 Q4

We've seen stronger results in the repo business for a handful of quarters now

Revenue GrowthDemandTranscript · FY2024 Q4 →
Show response

CEO noted repo is roughly 5% of total NII, so while investments have improved performance, it remains a small contributor. Expect growth but not a meaningful driver of total NII.

how important is fee operating leverage to the firm? I know you talk about total, which is right

MarginCost PressureTranscript · FY2024 Q4 →
Show response

CFO confirmed focus on both total and fee operating leverage through the cycle, noting multiple levers across NII, fees, and expenses provide flexibility to deliver the target.

IVZInvesco12 questions · 7 reporting periods · 1 of 12 challenging
IVZ company page →

Calendar 2026 Q2

how reliant are your gross sales in the QQQs from areas that can have just more sensitivity

ChallengingCompetitive DynamicsPricingTranscript · FY2026 Q2 →
Show response

Schlossberg cited breadth of the shareholder base and the proxy solicitation experience as evidence of low fee sensitivity, but gave no channel-level split of gross sales.

how quickly do you expect that to phase out in 2027? So does that all kinda go away in the first quarter

Cost PressureGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Dukes described a taper starting in Q1 2027 with some bleed-through but deferred formal 2027 guidance until closer to the year.

Calendar 2026 Q1

what does that look like today? And is there enough there to move the needle on the blended fee rate when it comes to that bucket as well for you guys?

Geographic ExpansionPricingTranscript · FY2026 Q1 →
Show response

Andrew noted 14 new launches ($2.5B inflows) but 75% of flows from existing products. Allison acknowledged new products launch at slightly lower fee rates but margins in high 50s to low 60s demonstrate platform strength. Fee rate compression likely to continue as mix shift story.

anything you guys would be willing to share and how you would potentially respond if competitors come in at a lower price point?

Competitive DynamicsPricingTranscript · FY2026 Q1 →
Show response

Andrew emphasized level licensing fees, total cost of ownership including spreads and liquidity, 25-year brand history with hundreds of millions invested, and ETF investors' demonstrated insensitivity to marginal fee differences.

Calendar 2025 Q4

Maybe it would be helpful just to kind of level set where you guys expect the total dollar amount of expenses to be for 2026, assuming sort of flat markets

Cost PressureMarginTranscript · FY2025 Q4 →
Show response

Allison declined to give total 2026 expense figure but confirmed $3.2B is right starting point, with 25% variable assumption and comp-to-rev around 40-41%. Committed to continuing operating margin expansion with mid-30s target on path to high-30s.

do you still see parts of the business that are sort of subscale where you could do something similar where you exit them or JV them or kind of try to maneuver them to where sort of it makes sense?

M&ACompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Andrew indicated foundational restructuring largely complete, shifting focus to execution across ETFs, SMAs, private markets, and Asia/EMEA growth. Allison noted no obviously subscale businesses remain but significant opportunity for performance improvement.

Calendar 2025 Q3

Maybe one, with the use of proceeds, obviously, you guys have been deleveraging, and there's more to do there, but maybe talk a little bit about capital return priorities as you look out over the n...

Capital AllocationCost PressureTranscript · FY2025 Q3 →
Show response

Allison detailed India ($140-150M proceeds, ~$6M/quarter OI impact) and Intelliflo ($100M proceeds, negligible OI impact). Capital priorities remain balanced: balance sheet improvement, 60% payout ratio, and growth investment. Total divestiture proceeds of $240-250 million.

Calendar 2025 Q2

curious how you're thinking about the licensing fee of 8 basis points relative to other rates that are out there in the market, how durable do you think that's going to be?

PricingCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Andrew declined to comment beyond the proxy, characterizing NASDAQ and Bank of New York as outstanding partners with no indication of fee renegotiation.

Calendar 2025 Q1

how you envision sort of the product and distribution opportunities develop with Barings and MassMutual

Show response

Andrew indicated first phase focuses on private credit for US wealth management, happening relatively quickly, with second and third phases following.

what ultimately got MassMutual over the hump to agree to this

Capital AllocationTranscript · FY2025 Q1 →
Show response

Allison cited multi-faceted partnership strength. Noted MassMutual is 18% common shareholder invested in stock rerating. Future discussions possible under repurchase agreement.

Calendar 2024 Q4

what are the runrate expenses you expect to pay State Street once all the assets have migrated over?

Cost PressureCapex InvestmentTranscript · FY2024 Q4 →
Show response

Allison declined to share State Street fee specifics citing contractual constraints but confirmed implementation costs of $10-15M/quarter will end post-migration.

talk to us maybe a bit about the pipeline that you are seeing in the products there and your expectations for flows over the next couple of quarters?

Geographic ExpansionDemandTranscript · FY2024 Q4 →
Show response

Andrew highlighted equity ETF demand growing in China, with balanced fixed income plus strategies also gaining traction amid government stimulus.

STTState Street Corporation11 questions · 6 reporting periods · 2 of 11 challenging
STT company page →

Calendar 2026 Q2

So as you think about the firm wide organic fee growth today, where does that stand

Revenue GrowthGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Woods framed positive operating leverage as the north star, with the $250M revenue uplift led by alternatives.

Calendar 2026 Q1

can you give us the overarching goals you are trying to achieve?

MarginRevenue GrowthTranscript · FY2026 Q1 →
Show response

John outlined four building blocks for July update: 1) increasing business execution discipline driving organic growth, 2) distinctive portfolio of strategic initiatives (digital, wealth, privates), 3) operating model transformation with agile ways of working, and 4) technology modernization and AI. Current guide implies ~31% pretax margin. Goal is both growth and improved profitability over medium term.

Any early thoughts on the implications that might have on both ETF growth for State Street Corporation and incremental expenses

Competitive DynamicsCost PressureTranscript · FY2026 Q1 →
Show response

Ron noted these platforms are close partners. STT has broadened from institutional to wealth and international channels. Any pocket impacts won't be substantial given the diversified ETF franchise.

Calendar 2025 Q4

it just feels like there's no organic growth really baked in in your 2026 numbers

ChallengingRevenue GrowthGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

John clarified: flat markets put fee revenue above midpoint of 4-6%; 5% market growth reaches upper end. Organic growth in 2025: ~2% servicing fees, ~3-4% management fees. Software transitioning from on-prem to SaaS creates temporary reporting headwind but underlying organic growth is high single digits. Markets business provides additional growth, variable with volatility.

should we expect a larger buyback or a larger payout for 2026?

Capital AllocationTranscript · FY2025 Q4 →
Show response

John noted 2025 payout was right around 80%, slightly below target due to late FDIC windfall increasing denominator, not lower dollar buyback. 2026 capital waterfall: protect/grow dividend, deploy RWA for client lending and markets, bolt-on M&A, then strong buyback. CET1 is the lead optimization metric despite technical leverage constraint.

Calendar 2025 Q3

is it a function of the balances being higher? I know that tend to pick up seasonally. Or is there something more more specific that you guys are already starting to work through?

CreditMacroeconomicTranscript · FY2025 Q3 →
Show response

John said balance sheet expected to be about stable in Q4, not the driver of NII improvement. Real drivers are investment portfolio reinvestment at higher yields and terminated interest rate hedges with negative drag running down in Q4, both continuing into 2026. Non-interest-bearing deposits held in and expected to continue stable.

How are you thinking about, both the balance sheet management and sort of operating dynamics in the company?

MarginCapital AllocationTranscript · FY2025 Q3 →
Show response

John outlined four priorities: partnering with management on execution/profitability, balance sheet optimization opportunities, productivity initiatives with tailwinds into 2026, and geographic expansion/product development. Noted solid deposit trends and NIM flat QoQ with NII/NIM headed up in Q4.

Calendar 2025 Q2

the redemptions have been fairly elevated. Obviously, part of that is BlackRock. But are you, I guess, aware of anything notable on the redemption side that could sort of offset some of the strong ...

ChallengingRevenue GrowthCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Ron emphasized operating model investments driving improved service quality, which both raises retention and enables wins. Alpha driving wins across the stack. Mark provided historical context: $140-160M sales in 2019-2020, now $145M in Q2 alone, 'That's more in the second quarter than we did in all of 2020.'

help us maybe think about what are the things you guys could do and what are you working on to perhaps mitigate the effects of lower interest rates as you look out beyond this year

CreditMacroeconomicTranscript · FY2025 Q2 →
Show response

Mark declined to get into 2026 specifics but mentioned deposit pricing, balance sheet strategy, and investment portfolio positioning as active areas of focus.

Calendar 2025 Q1

I was hoping you can bifurcate between interest-bearing and non-interest deposits trends

Show response

Mark noted NIB decline came from asset manager and asset owner clients, expected from seasonal Q4 highs. Client deposits now tracking toward $240 billion high end of range.

what holding up better in the business to fill the gap, I guess, from the market impact on fees in 2025 to keep your guidance largely intact

Revenue GrowthGuidance ReliabilityTranscript · FY2025 Q1 →
Show response

Ron cited installation backlog and pipeline momentum. Mark highlighted $370M trailing four-quarter sales and record $356M to-be-installed revenue as core business momentum that hasn't changed.

BENFranklin Resources10 questions · 7 reporting periods · 0 of 10 challenging
BEN company page →

Calendar 2026 Q2

How are you thinking about the opportunity in fixed income broadly and how much they could accelerate growth for Franklin

Revenue GrowthCompetitive DynamicsTranscript · FY2026 Q3 →
Show response

Johnson described a unified public-private fixed income platform of $620 billion including $100 billion private, plus Western integration; Gamba cited multi-asset credit wins. Direct.

maybe it’s worthwhile just kind of fleshing out how you think about buybacks from here and the capital management approach

Capital AllocationTranscript · FY2026 Q3 →
Show response

Nicholls detailed capital priorities and explained that the elevated buyback included repurchasing Great-West Life's stake above its 4.9% lockup. Direct.

Calendar 2026 Q1

I was hoping you could break that down by key strategies as well as whether Lexington, their flagship fund, contributed to that at all

Revenue GrowthProduct LaunchTranscript · FY2026 Q2 →
Show response

Jenny: credit was largest contributor, Lexington meaningful but can't detail flagship. Over 30 vehicles contributed across credit, secondary PE, real estate, venture. No catch-up fees. Lexington on track, flagship update via filing in second half of year. Expect to exceed $30B annual target. Matt clarified: approximately 90% of alt AUM has fee-earning potential, current fee-generating is about 80% of $283B total.

Calendar 2025 Q4

Where do you see the profitability over time? Many of your peers are well in the thirties

MarginCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Matt stated 30% margin target in fiscal 2027, 30-35% achievable over 5-year plan. Western support costing several points of margin. High 20s margin guidance for FY2026 assumes flat markets. If markets stay current levels, upside to plan. Scaling of ETFs, Canvas, and Solutions creating higher margins at current size despite lower fees.

Calendar 2025 Q3

your just total expense guide for 2026 in totality?

MarginCost PressureTranscript · FY2025 Q4 →
Show response

Matt confirmed $200M gross efficiencies achieved, now determining net amount. Self-funding growth investments, absorbing Apera ($30M), increased fundraising expenses, and Aladdin project. Market up 15-20% to start year helps. Margin expected to tick up each quarter (Q1 lower by ~2% from accelerated deferred comp). Targeting 30% margin.

Can you just unpack how much you assume for Lexington's flagship fund?

Revenue GrowthProduct LaunchTranscript · FY2025 Q4 →
Show response

Jenny detailed $25-30B FY2026 target as mix of Lexington (up to half), Clarion, BSP, Alcentra, and Venture. Prior year achieved $22.7B even without Lexington first close. Expects FY2026 to be well-rounded across all alt managers.

Calendar 2025 Q2

expense guidance just as you kind of progress here towards the end of the fiscal year

Cost PressureMarginTranscript · FY2025 Q3 →
Show response

Matt gave detailed Q4 guidance: comp $860-870M (includes $100M perf fees at 60% payout), IS&T $155M, occupancy $69-70M, G&A $190-195M. Total ~$1.283-1.285B. FY2025 slightly above flat ($20-30M higher) despite higher markets. FY2026: $200M+ run rate savings minus Apera ($30M) and potential higher alt distribution expenses.

I wanted to get your guys' thoughts on the outlook for private markets growth for Franklin over the next 12 months

Revenue GrowthProduct LaunchTranscript · FY2025 Q3 →
Show response

Jenny updated alt fundraising to ~$18.5B expected for FY2025. Lex Fund XI first close pushed to December 2025 or early 2026. Wealth channel at 25% of YTD fundraising. Flex and Flex International seeing $150-200M/month. Added 16 international distributors. BSP perpetual real estate debt fund launched with 1 wirehouse, expanding internationally. 90 dedicated alt specialists, still adding headcount.

Calendar 2025 Q1

would love to get your insight on how the retail products have done, through April

Product LaunchRevenue GrowthTranscript · FY2025 Q2 →
Show response

Private markets at $10.4B of $13-20B target. Lexington Fund 11 first close pushed from September to later in 2025 or early 2026. Still expect mid-range of fundraising target. Fund 11 expected bigger than Fund 10's $22.7B.

Calendar 2024 Q4

can you help us frame the operating income and management fee contribution from Western, kind of where that stands today?

Show response

Matt detailed Western at ~6% of Franklin adjusted revenue remaining. $120B outflows = 30% of Western's FY24 revenue = 3% of Franklin. Integration of corporate functions accelerated as 5-year autonomous agreement expires July.

ARESAres Management Corporation8 questions · 7 reporting periods · 0 of 8 challenging
ARES company page →

Calendar 2026 Q2

where on your priority list is something inorganic on the private equity side?

M&ACapital AllocationTranscript · FY2026 Q2 →
Show response

Mike declined to address deal rumors but laid out the M&A framework (culturally, strategically, and financially accretive) and made the case for scaling private equity.

Calendar 2026 Q1

Can you expand on which parts of the Credit business you have seen the biggest incremental pickup in deployment opportunities

DemandCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Arougheti pushed back on the premise that non-traded BDCs were the incremental buyer, noting the diversified deployment across Infrastructure, Real Estate, European Direct Lending, and Secondaries.

Calendar 2025 Q4

can you unpack that a little more between direct lending products versus other well vehicles that you guys have

Subscriber GrowthDemandTranscript · FY2025 Q4 →
Show response

Mike emphasized intentional slow wealth channel build to maintain institutional drawdown buffer. January $1.2B and February tracking similarly. ACI saw $750M inflows in Jan-Feb vs $200M prior year. About 95% of investors not seeking liquidity. Some outflows driven by small number of investors repeatedly queuing.

Calendar 2025 Q3

how you envision your franchise position in case LP appetite starts to normalize and resume in the real estate channel

DemandCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Mike highlighted third largest institutional real estate manager position, vertical integration, and 51% QoQ / 78% YoY deployment growth in real estate. Identified supply constraint tailwinds and rate-driven transaction volume recovery.

Calendar 2025 Q2

how compression in U.S. direct lending spreads impacting institutional demands and fee rates

Show response

Mike pushed back on fee pressure narrative, noting some peers cutting fees to attract capital. Private credit spreads 100-200bps wide vs liquid loans, high-grade book 60-90bps wide. Growth driven by consolidated market share gains.

Calendar 2025 Q1

what are the more likely areas of deployment where the firm could stay active?

Capital AllocationDemandTranscript · FY2025 Q1 →
Show response

Mike cited historical resilience: FPAUM grew 23% in 2022 when M&A was down 25%. Identified opportunistic credit (ASOF), secondaries, alternative credit, and ARCC pivot capacity as key deployment areas when M&A slows.

Calendar 2024 Q4

Can you guys just level set and remind us what their 2024 full-year management fee base is

Show response

Jarrod detailed $200M FRE in first 12 months, $245M in 2026, with $10M synergies and $10M integration costs. Mike added near-term fundraising pipeline of approximately $8B across data centers and real estate.

can you talk a little bit about the changes you're seeing in that LP base?

DemandCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Mike noted high-grade demand is predominantly insurance-focused with some bank partnerships and sovereign interest. Viewed as distinct from sub-investment-grade private credit expansion.

Show 12 more companies
NTRSNorthern Trust8 questions · 4 reporting periods · 0 of 8 challenging
NTRS company page →

Calendar 2026 Q1

With the Visa shares become available to you guys this year. Can you maybe just talk through the amount of proceeds you expect the use of these proceeds and timing when it comes to potentially bigg...

Capital AllocationTranscript · FY2026 Q1 →
Show response

Fox said approximately $470M pretax ($350M posttax) from half the Visa position. Not planning to use the same playbook as a few years ago, weighing against other priorities. Haven't landed on specific use yet.

Can we talk through maybe the areas where you see the most opportunity to accelerate growth? And ultimately, what you think Northern's organic fee growth, so, ex markets, should look like over the ...

DemandRevenue GrowthTranscript · FY2026 Q1 →
Show response

O'Grady detailed growth levers by segment: WM needs talent additions plus digital marketing and centers of influence; AS focused on scalable growth within current footprint at profitable margins; AM investing in ETFs, tax-advantaged equity, and quant with third-party distribution buildout. Targeting 3% organic growth firm-wide but hopes to exceed.

Calendar 2025 Q2

how you're thinking about the trajectory from NII off of that jumping off point? And are there any things you could do today to mitigate the effects of potentially lower interest rates

Revenue GrowthCreditTranscript · FY2025 Q2 →
Show response

Fox highlighted $1.5B quarterly securities rolloff reinvested at 100bp above runoff yield, deposit pricing focus across multiple currencies, and extending duration to protect not just H2 2025 but 2026 as well.

as you think about how long it will take you guys to get there, and ultimately, what interest environment does that contemplate?

Show response

O'Grady estimated 2027 timeline under a normalized yield curve with gradual rate declines, noting current quarters provide chunkier operating leverage gains while acknowledging some periods will require more grinding.

Calendar 2025 Q1

give us an update on kinda how things stand so far in April both in terms of the level and the mix

DemandRevenue GrowthTranscript · FY2025 Q1 →
Show response

Fox confirmed deposit levels holding well into April with clients maintaining risk-off positions. No expectation of near-term abatement.

the percentage of your expense base that flexes directly with lower asset levels?

Show response

Fox noted very low variable expense ratio of less than 0.5%, meaning expense reduction from lower markets is minimal. 10% market decline translates to roughly 3% trust fee change.

Calendar 2024 Q4

has that changed at all, meaning that if you are in a sort of better fee environment in 2025

Cost PressureMarginTranscript · FY2024 Q4 →
Show response

O'Grady acknowledged some variable cost but emphasized driving the expense curve down regardless of revenue environment.

as you think about the expense to fee ratio, which would kind of normalize for that flex, so to speak

MarginGuidance ReliabilityTranscript · FY2024 Q4 →
Show response

O'Grady declined to give a specific 2025 target but confirmed continued progress toward the 105-110% medium-term range from current 113%.

APOApollo Global Management7 questions · 7 reporting periods · 1 of 7 challenging
APO company page →

Calendar 2026 Q2

what pools of investing capital do you think this will open up for Apollo and perhaps some of the others

DemandInnovation & R&DTranscript · FY2026 Q2 →
Show response

Rowan mapped daily NAV and transparency to new capital pools: 401(k)/DC, traditional asset managers, and individual investors.

Calendar 2026 Q1

the durability of the origination volumes and the transaction fees you guys are seeing

Revenue GrowthCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Zelter emphasized growth across Apollo's proprietary ecosystem beyond platforms, highlighting AI infrastructure financing and partnership with banks. Rowan added this extends to energy, defense, and manufacturing globally.

Calendar 2025 Q4

it's been a little bit more turbulent with redemptions picking up and sales have generally slowed down, and that's really even before all the software headlines

ChallengingCompetitive DynamicsCreditTranscript · FY2025 Q4 →
Show response

Zelter noted ADS had net new assets up every quarter in 2025 with over $5B net inflows. Software exposure negligible on PIK, ARR, and pre-2022 vintage bases. Expect to gain market share and highlighted ABC as diversification opportunity.

Calendar 2025 Q3

I was intrigued by your comments around the asset management partnerships broadly. So maybe you could expand a little bit on how you view this $5 billion trajectory from here?

Subscriber GrowthCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Rowan outlined a tiered wealth strategy: family offices (direct), HNW (via intermediaries), and mass market (via traditional manager partnerships). Expects billions at a time from traditional asset manager partnerships.

Calendar 2025 Q2

double-click into credit spread dynamics and importantly, how that could impact the insurance business perhaps beyond 2025

CreditCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Rowan explained COVID-era spread runoff as the reason for current SRE compression, with a meaningful tick up expected once it completes. Pivoting origination away from commoditized CLOs to proprietary products.

Calendar 2025 Q1

When you think about how your institutional client base is responding and appreciate you guys actually don't have a large flagship fund in the market today

DemandCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Zelter and Rowan both emphasized Apollo has historically under-earned its share of institutional assets, sees increasing insurance client demand, and views origination as the binding constraint.

Calendar 2024 Q4

your expectations for origination into 2025. The way you framed it, I thought it was really helpful between Atlas lender finance, and direct lending.

DemandM&AGeographic ExpansionTranscript · FY2024 Q4 →
Show response

Zelter provided a comprehensive breakdown of geographic expansion plans for Atlas, growth in high-grade capital solutions and hybrid origination, and the bank partnership pipeline.

BLKBlackRock7 questions · 7 reporting periods · 0 of 7 challenging
BLK company page →

Calendar 2026 Q2

Larry, I was hoping to go back to your comments around GIP and HPS performing ahead of the plan

Show response

Larry quantified 2026 insurance mandates, described the $800 billion insurance asset base conversion opportunity, and stressed HPS/GIP origination integration.

Calendar 2026 Q1

You mentioned in your prepared remarks that in prior periods of dislocation, BlackRock, Inc. tends to gain share

Competitive DynamicsRevenue GrowthTranscript · FY2026 Q1 →
Show response

Larry highlighted positioning in retirement, infrastructure, iShares breadth. Martin noted top five managers capture 80%+ of flows, with structural growers and whole-portfolio consolidation as dual growth vectors.

Calendar 2025 Q4

how should we think about that progressing over the course of '26, assuming kind of normal markets?

MarginCost PressureTranscript · FY2025 Q4 →
Show response

Martin detailed FRE margin trajectory toward 50%+ driven by private markets growth. Ex performance fees, Q4 margin was 45.5%, up 30bps YoY. Mid-single-digit G&A increase expected for 2026 after annualizing HPS/Preqin. Headcount broadly flat.

Calendar 2025 Q3

what the HPS team is seeing on the ground, both with respect to credit trends across their direct lending portfolios in the third quarter

Show response

Martin explained headlines about private credit stress are in syndicated bank loan and CLO markets, not large direct lending books. Private credit lenders have more control over agreements and information. HLEND and B debt seeing steady allocations with strong deployment.

Calendar 2025 Q2

help us sort of think through the cadence and scaling of the business as these 2 acquisitions kind of come into the full run rate

Show response

Martin explained Q2 margin of 43.3% down 80bps driven by lower performance fees. Entry rate into Q3 approximately 10% higher including HPS. Controllable expenses aligned with 7% organic revenue growth. Expects acquisitions to be self-funding with double-digit FRE growth.

Calendar 2025 Q1

Does that mean BlackRock might need to get even larger outside the U.S.?

Geographic ExpansionM&ATranscript · FY2025 Q1 →
Show response

Larry said no acquisitions needed outside U.S.; partnerships with governments (India, Saudi Arabia, LatAm) and 40% European ETF market share provide sufficient scale. Expanding to 34-35 countries by year end.

Calendar 2024 Q4

to what extent does that change the backdrop you're seeing in the marketplace today?

DemandCapital AllocationTranscript · FY2024 Q4 →
Show response

Martin provided comprehensive breakdown of organic growth drivers across ETFs, private markets, fixed income, and cash. Larry added color on yield curve steepening and $10T cash rotation opportunity.

BXBlackstone Inc.7 questions · 7 reporting periods · 2 of 7 challenging
BX company page →

Calendar 2026 Q2

I would love to double click on what you guys are seeing in the wealth channel.

Subscriber GrowthCreditTranscript · FY2026 Q2 →
Show response

Gray reported wealth strength with muted BCRED flows recovering, and framed Wellington/Vanguard as additional distribution engines that take time to build.

Calendar 2026 Q1

the wealth channel is clearly still going through some growing pains, right? I mean, we see quite significant reaction in the channel

ChallengingCreditDemandRegulation PolicyTranscript · FY2026 Q1 →
Show response

Gray pushed back firmly, arguing social media narrative diverges from facts. Cited BREIT's 9.5-year track record with only 1 year of limited liquidity and 60% return premium. Defended disclosure practices.

Calendar 2025 Q4

On the one hand, obviously, we saw redemptions pick up, not surprisingly, last quarter. Gross sales on gen one. Looks like they slowed down a little bit in BCRED still. So what is the sentiment fro...

ChallengingCreditSubscriber GrowthTranscript · FY2025 Q4 →
Show response

Gray acknowledged BCRED redemption uptick from headlines but noted $14B gross sales in 2025 and $800M+ monthly inflows continuing. Institutional side accelerating with IG private credit delivering 180bps premium driving insurance demand.

Calendar 2025 Q3

how important is the sort of 10-ish percent gross return to the retail channel? So does the point you make, does that resonate or it's really viewed as an absolute product?

CreditProduct LaunchTranscript · FY2025 Q3 →
Show response

Gray said relative premium over liquid credit matters more than absolute return, BCRED flows remain healthy post-dividend cut, and multi-asset offerings will leverage BX's unique product breadth.

Calendar 2025 Q2

we're clearly seeing compression in credit spreads. And I'm curious how that's playing into your client conversations where the premium to liquid market is still there

Show response

Gray argued the enduring private-to-liquid spread premium is what matters, not absolute returns, and that demand remains extraordinarily robust across IG and non-IG globally.

Calendar 2025 Q1

curious to kind of how you think about the origination opportunity for Blackstone in IG private credit in light of potentially lose lending requirements on the bank side?

Regulation PolicyCreditTranscript · FY2025 Q1 →
Show response

Gray argued BX's value proposition is bespoke flexibility and certainty of execution for borrowers, while banks can be origination partners rather than competitors.

Calendar 2024 Q4

Can you give us a sense of the amount of capital that's sitting on the platform now that's not earning fees yet that will turn on upon deployment?

Revenue GrowthCapital AllocationTranscript · FY2024 Q4 →
Show response

Chae quantified ~$40B eligible but not yet earning fees in credit plus ~$9B in real estate credit, with Gray noting deployment should keep pace with inflows.

KKRKKR7 questions · 7 reporting periods · 1 of 7 challenging
KKR company page →

Calendar 2026 Q2

talk through some of the biggest drivers of management fee growth into next year given the tough comps

Revenue GrowthDemandTranscript · FY2026 Q2 →
Show response

Answered with the forward indicators (30-plus products, record committed capital not yet fee-bearing) but gave no fee growth rate for 2027.

Calendar 2026 Q1

As you think on the forward, it might be helpful just to get a mark-to-market on your expectations for fundraising

Subscriber GrowthRevenue GrowthTranscript · FY2026 Q1 →
Show response

Craig detailed diversified fundraising across PE, credit, real assets and wealth. Flagships were only 15% of Q1 capital raised. Scott added consolidation theme is playing out with clients wanting to do more with fewer partners.

Calendar 2025 Q4

Can you talk maybe through the building blocks, your confidence levels in those building blocks?

Revenue GrowthGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Rob walked through FRE components: record capital raising driving management fee momentum, capital markets well-positioned for increased deployment, insurance capital markets fees scaling from ~$60M to hundreds of millions, fee-related performance revenue inflecting. Highlighted 46% mgmt fee growth vs 21% OpEx growth since end of 2022, inverse of three closest peers.

Calendar 2025 Q3

it might be helpful just to kind of go through the broader building blocks as you look through current fundraising dynamics

Revenue GrowthGuidance ReliabilityTranscript · FY2025 Q3 →
Show response

Rob confirmed leaning into the plus on $4.50 FRE target. $300B+ fundraising 70%+ achieved in 7 of 12 quarters. Capital Markets biased to upside in 2026. Fee-related performance revenue scaling materially.

Calendar 2025 Q2

Is that still the case? How are you sort of gauging the pulse of institutional clients as you go through this fundraising cycle?

DemandCapital AllocationTranscript · FY2025 Q2 →
Show response

Scott confirmed $217B raised in last 2 years, ahead of $300B+ target pace. Institutions consolidating relationships and doing more with fewer partners, benefiting KKR across infrastructure, credit, and ABF.

Calendar 2025 Q1

with the stock doing what it's done over the last few months, why not step up the buyback here?

ChallengingCapital AllocationCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Rob emphasized consistency in capital allocation framework across four buckets (buybacks, core PE, strategic M&A, insurance). Noted 30% management ownership alignment but gave no specific buyback commitment.

Calendar 2024 Q4

Could you just maybe walk us through sort of why now? Why is now the right time to add?

Capital AllocationCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Craig explained SH owns ~20% of core PE businesses. Scott added Chubb investing alongside for the $2.1B+ add-on, with timing driven by partner liquidity needs and portfolio maturity.

NDAQNasdaq, Inc.7 questions · 7 reporting periods · 0 of 7 challenging
NDAQ company page →

Calendar 2026 Q2

how do you think about the margins as a whole over the next couple of years?

Show response

Sarah cited the widening revenue-to-expense gap and continued GenAI-driven efficiencies but gave no specific margin target.

Calendar 2026 Q1

I was hoping you can give us a little more detail on where you're seeing the incremental uptake, particularly within cap markets as well as your view for the rest of the year

Revenue GrowthSubscriber GrowthTranscript · FY2026 Q1 →
Show response

Friedman attributed broad-based strength to trade management services connectivity demand and pricing increase, Calypso collateral management demand especially internationally, Market Technology Eclipse platform adoption and new intelligence suite data management add-on.

Calendar 2025 Q4

how are you thinking about M&A broadly? Is organic growth still the primary focus for the firm for the next call at couple of years?

M&ACapital AllocationTranscript · FY2025 Q4 →
Show response

Friedman reaffirmed organic growth as primary focus with bolt-on acquisitions evaluated in build versus buy orientation. Organic opportunity set described as tremendous with team fully focused on execution.

Calendar 2025 Q3

curious how you sort of think about areas of risk when it comes to AI with respect to Nasdaq's revenue model and as an offset potentially incremental revenue opportunities as well as areas where th...

Cloud & AIInnovation & R&DTranscript · FY2025 Q3 →
Show response

Friedman described dual AI program: business-side automation of product development 'keep the lights on' work and client implementation/experience, product-side differentiation through proprietary data, deep domain expertise, and Agentic AI reducing compliance workflow time by 80%.

Calendar 2025 Q2

how we should be thinking about the momentum in fintech entering into '26

Revenue GrowthSubscriber GrowthTranscript · FY2025 Q2 →
Show response

Friedman confirmed healthy pipeline maturity across all FinTech products globally, with Tier 1/2 FCMT revenue expected to ramp in Q4 and into 2026.

Calendar 2025 Q1

What is the probability of deals you're seeing out there Obviously, macro uncertainty could present pretty compelling valuation opportunities

M&ACapital AllocationTranscript · FY2025 Q1 →
Show response

Friedman clearly shut down M&A discussion, emphasizing laser focus on organic growth, deleveraging commitments, and Adenza returns before considering inorganic moves.

Calendar 2024 Q4

your outlook on Workflow and Insights. Obviously, it is a business that has been growing a little bit slower

Revenue GrowthDemandTranscript · FY2024 Q4 →
Show response

Friedman acknowledged headwinds from slower IPOs and delistings, cited eVestment growing high single digits, and expects recovery as economic growth broadens.

ICEIntercontinental Exchange6 questions · 6 reporting periods · 0 of 6 challenging
ICE company page →

Calendar 2026 Q2

how are you thinking about the mix and the revenue model evolving over time as you guys integrate this business?

M&ARevenue GrowthCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Edmonds pointed to prior playbooks without naming a target mix. Gardiner added the concrete point that ICE is undersized in EMEA and Asia Pacific and can sell data into those regions.

Calendar 2026 Q1

the recurring revenue improvement sequentially, where that sort of coming from

Subscriber GrowthRevenue GrowthTranscript · FY2026 Q1 →
Show response

Management detailed legacy renewal headwinds subsiding, 30% Encompass transaction growth, strong sales pipeline with JPMorgan, M&T, and Huntington Bank cross-sells.

Calendar 2025 Q3

What in terms of actual savings you guys think this can produce for the firm? What's the time frame on that?

Show response

Ben described AI enabling 'more with the same' headcount rather than direct cost savings. Speed to market for new products. Did not quantify specific dollar savings or margin impact timeline.

Calendar 2025 Q2

help us understand a little better how they could translate into either new or improved revenue opportunities for ICE as a whole

Capex InvestmentInnovation & R&DTranscript · FY2025 Q2 →
Show response

Chris said about half of current capacity built out with runway through early 2030s. Proprietary network under ICE control with scheduled buildout alongside client needs and power availability.

Calendar 2025 Q1

Can you kind of help us sort of think how that could impact the customers need to hedge and just sort of the broader activity in your energy markets

DemandMacroeconomicTranscript · FY2025 Q1 →
Show response

Ben emphasized growing risk factors (tariffs, recession, energy security, AI demand) driving more hedging. Open interest up 8% even on back of 30% energy growth proves market health.

Calendar 2024 Q4

ICE made a nice progress gaining market share over the course of last year. It looks like trends have picked back up again on the market share trend versus your primary competitor there

Competitive DynamicsRevenue GrowthTranscript · FY2024 Q4 →
Show response

Ben Jackson attributed WTI gains to Midland WTI HOU contract innovation, physically delivered with double the deliveries of competitor. Cross-product trading efficiency drives bundled volume.

SCHWCharles Schwab Corporation6 questions · 6 reporting periods · 0 of 6 challenging
SCHW company page →

Calendar 2026 Q2

specifically zoning in on Q4 NIM guidance, which I think you said 3.25% to 3.30%

MarginGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Attributed the flat Q4 NIM guide to the December rate-hike timing not benefiting 2026; expects further expansion into 2027.

Calendar 2026 Q1

what you're hearing on the ground from advisers with respect to their reception to Evergreen private alts

Competitive DynamicsProduct LaunchTranscript · FY2026 Q1 →
Show response

Wurster acknowledged alternatives allocation is relatively small today but expects 5-10 year growth, with opportunities to curate and monetize. Verdeschi noted long-short strategies are not capital-intensive due to netting but confirmed they monitor strategy evolution.

Calendar 2025 Q4

maybe just level set us what you assume for buybacks then? And again, how are you thinking about longer-term trajectory?

Capital AllocationTranscript · FY2025 Q4 →
Show response

Mike confirmed 2026 scenario EPS does not include buybacks. Capital framework unchanged: 20-30% GAAP earnings dividend payout, potential preferred redemptions or replacements, and opportunistic buybacks above franchise growth needs.

Calendar 2025 Q3

how are you thinking of that over the next couple of quarters here? Because obviously, it's a pretty important component

Show response

Mike confirmed normalized cash environment with organic growth, seasonality, and sentiment as drivers. Lower rates expected to support further cash pickup heading into 2026.

Calendar 2025 Q2

How are you thinking about that? What do you think is the ultimate profitability destination for the firm

Show response

Mike pointed to balanced approach of investing in growth and scale/efficiency enabling natural margin expansion, though environment-dependent. Declined to give specific long-term target.

Calendar 2024 Q4

Could you guys spend a minute on your securities portfolio strategy as you roll through 2025

Capital AllocationCreditTranscript · FY2024 Q4 →
Show response

Mike confirmed ~$10B quarterly portfolio runoff will continue to fund supplemental paydown near-term, with reinvestment at higher yields an eventual opportunity.

AMPAmeriprise Financial5 questions · 3 reporting periods · 0 of 5 challenging
AMP company page →

Calendar 2025 Q3

help us think about the reinvestment yields you expect on that book as that rolls off over the next couple of quarters

Show response

Walter confirmed reinvesting at high 4s to low 5s on maturities, maintaining bank NII. Comfortable with strategy for next 3 quarters, less certainty beyond depending on Fed and long-term rates.

those balances have been coming down now for several quarters, which makes sense, I guess, given how elevated they've been running at

Show response

Walter indicated certs balance decline is spread-driven and follows a predictable pattern. Pre-2023 levels of $5-6B may be the floor but doesn't expect precipitous drop at this stage.

Calendar 2025 Q2

I was hoping you guys can give us a sense of roll-on, roll- off dynamics in the bank securities portfolio

Show response

Walter confirmed portfolio maturities rolling into wider spreads, contributing to NII improvement. Funding loans through new liability products like CDs and high-yield savings.

Calendar 2025 Q1

how do you guys think that is likely to evolve here through 2025, relative to last year?

MarginProduct LaunchTranscript · FY2025 Q1 →
Show response

Walter confirmed CDs are incremental to existing sweep business. Bank earnings expected to be quite stable. Confident in ability to navigate Fed rate changes.

that gives you an opportunity perhaps to be a little more proactive, a little more opportunistic in this environment

Capital AllocationM&ATranscript · FY2025 Q1 →
Show response

Jim clarified it was a general statement about flexibility, not specific M&A targets. Board approved larger buyback program for market flexibility.

CMECME Group5 questions · 4 reporting periods · 1 of 5 challenging
CME company page →

Calendar 2026 Q2

You think the time is sort of ripe now for these to be more successful. Why now? I guess, what makes it different?

Product LaunchDemandTranscript · FY2026 Q2 →
Show response

Terry framed the timing on market evolution; Tim gave equity-complex momentum stats and Julie Winkler covered retail distribution readiness.

Calendar 2026 Q1

Obviously, with a lot of volumes coming through, RPCs came down a bit

ChallengingPricingMarginTranscript · FY2026 Q1 →
Show response

Lynne cited four factors: volume tiering at record levels, mix shift toward lower-priced crude, micro energy contracts surging from 80K to 315K ADV at $0.52 RPC, and more member trading.

curious to get your thoughts on the health of the underlying customer. Obviously, we've seen extreme volatility

DemandCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Derek noted open interest in energy up 14% since Dec 31 with every client segment growing double digits led by commercials. Terry distinguished good vs bad volatility, noting headline volatility is normally short-lasting.

Calendar 2025 Q2

just curious how you could see your ecosystem impacted by this, whether it's in the rates business or any other products could potentially benefit

Regulation PolicyDemandTranscript · FY2025 Q2 →
Show response

Terry views SLR relief as a net positive for CME. Mike Dennis noted it's still in public comment period with impact depending on bank-specific implementation.

Calendar 2025 Q1

You help break down the composition of retail in terms of just the revenues where that stands now?

Subscriber GrowthRevenue GrowthTranscript · FY2025 Q1 →
Show response

Terry declined to share granular retail revenue breakdown but attributed durability to technology democratization, new brokers offering futures, and larger/more diverse retail market than prior cycles.

TROWT. Rowe Price5 questions · 5 reporting periods · 1 of 5 challenging
TROW company page →

Calendar 2026 Q2

are there more significant action you could take to bring down the pace of expense growth more structurally

ChallengingCost PressureMarginTranscript · FY2026 Q2 →
Show response

Dardis pointed to AI/tech productivity, third-party leverage, process automation, vehicle rationalization, and real-estate reductions, targeting low single-digit controllable expense growth. Direct.

Calendar 2025 Q4

how you guys are planning from an operating perspective for 2026. Heard this expense guide, so maybe just remind us of the ability to flex up or down

Cost PressureMarginTranscript · FY2025 Q4 →
Show response

Rob emphasized market returns as primary margin driver; declined to comment on margin profile over time. Jen detailed expense guide components including controllable and market-driven buckets.

Calendar 2025 Q2

I was hoping to get your latest views on acquisitions for T. Rowe with respect to both thinking about opportunities in the 401(k) channel

M&ACapital AllocationTranscript · FY2025 Q2 →
Show response

Rob reiterated high M&A bar: cultural alignment, new capability, or client access. Jen added range of options now spans full acquisition to minority investment.

Calendar 2025 Q1

help us understand the drivers between sort of the original guide versus we are now. And as of what point, I guess, in April did you guys set the guide

Cost PressureMarginTranscript · FY2025 Q1 →
Show response

Jen explained the move from 4-6% to 1-3% reflects both natural market-driven adjustment and intentional controllable expense management.

Calendar 2024 Q4

Is there room to bend that kind of non, sort of variable part of the expense base to be more aligned, with the organic revenue growth

Cost PressureMarginTranscript · FY2024 Q4 →
Show response

Rob acknowledged need for structural cost reduction but emphasized continued investment in growth areas. Jen outlined 2-3% annual structural savings target.

CBOECboe Global Markets1 question · 1 reporting period · 1 of 1 challenging
CBOE company page →

Calendar 2026 Q2

How do you think that will impact competition in the space? What gives Cboe ultimately the right to win?

ChallengingCompetitive DynamicsPricingTranscript · FY2026 Q2 →
Show response

Craig defended the open all-to-all, centrally-cleared model's network effects over vertically integrated silos; Rob cited cross-market risk offsets; Prashant cited 50M+ retail clients on partner platforms. Direct.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
RJF Raymond James Financial1613%2 of 16 questions
BNY BNY Mellon130%none of 13 questions
IVZ Invesco128%1 of 12 questions
STT State Street Corporation1118%2 of 11 questions
BEN Franklin Resources100%none of 10 questions
ARES Ares Management Corporation80%none of 8 questions
NTRS Northern Trust80%none of 8 questions
APO Apollo Global Management714%1 of 7 questions
BLK BlackRock70%none of 7 questions
BX Blackstone Inc.729%2 of 7 questions
  • RJF
    Raymond James Financial · 16 questions
    13%2 of 16 questions
  • BNY
    BNY Mellon · 13 questions
    0%none of 13 questions
  • IVZ
    Invesco · 12 questions
    8%1 of 12 questions
  • STT
    State Street Corporation · 11 questions
    18%2 of 11 questions
  • BEN
    Franklin Resources · 10 questions
    0%none of 10 questions
  • ARES
    Ares Management Corporation · 8 questions
    0%none of 8 questions
  • NTRS
    Northern Trust · 8 questions
    0%none of 8 questions
  • APO
    Apollo Global Management · 7 questions
    14%1 of 7 questions
  • BLK
    BlackRock · 7 questions
    0%none of 7 questions
  • BX
    Blackstone Inc. · 7 questions
    29%2 of 7 questions
Show all 18 companies
CompanyQuestionsChallenge rate
KKR KKR714%1 of 7 questions
NDAQ Nasdaq, Inc.70%none of 7 questions
ICE Intercontinental Exchange60%none of 6 questions
SCHW Charles Schwab Corporation60%none of 6 questions
AMP Ameriprise Financial50%none of 5 questions
CME CME Group520%1 of 5 questions
TROW T. Rowe Price520%1 of 5 questions
CBOE Cboe Global Markets1—Rate withheld: fewer than 3 questions
  • KKR
    KKR · 7 questions
    14%1 of 7 questions
  • NDAQ
    Nasdaq, Inc. · 7 questions
    0%none of 7 questions
  • ICE
    Intercontinental Exchange · 6 questions
    0%none of 6 questions
  • SCHW
    Charles Schwab Corporation · 6 questions
    0%none of 6 questions
  • AMP
    Ameriprise Financial · 5 questions
    0%none of 5 questions
  • CME
    CME Group · 5 questions
    20%1 of 5 questions
  • TROW
    T. Rowe Price · 5 questions
    20%1 of 5 questions
  • CBOE
    Cboe Global Markets · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q320%none of 2 questions1
2024 Q4190%none of 19 questions14
2025 Q1229%2 of 22 questions16
2025 Q22110%2 of 21 questions17
2025 Q3190%none of 19 questions14
2025 Q41718%3 of 17 questions13
2026 Q12110%2 of 21 questions15
2026 Q22015%3 of 20 questions16
  1. 2024 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
  2. 2024 Q419 questions · challenge rate 0% (none of 19 questions) · 14 companies
  3. 2025 Q122 questions · challenge rate 9% (2 of 22 questions) · 16 companies
  4. 2025 Q221 questions · challenge rate 10% (2 of 21 questions) · 17 companies
  5. 2025 Q319 questions · challenge rate 0% (none of 19 questions) · 14 companies
  6. 2025 Q417 questions · challenge rate 18% (3 of 17 questions) · 13 companies
  7. 2026 Q121 questions · challenge rate 10% (2 of 21 questions) · 15 companies
  8. 2026 Q220 questions · challenge rate 15% (3 of 20 questions) · 16 companies

Topics

Topics tagged on this analyst’s questions.

  • Revenue Growth37
  • Margin34
  • Demand30
  • Capital Allocation28
  • Competitive Dynamics26
  • M&A17
  • Credit17
  • Cost Pressure16
  • Product Launch11
  • Subscriber Growth11
Show all 18 topics
  • Guidance Reliability9
  • Pricing8
  • Macroeconomic6
  • Innovation & R&D5
  • Cloud & AI5
  • Regulation Policy4
  • Geographic Expansion4
  • Capex Investment3